Replies to post #55895 on Biotech Values

[Spitz]

Both Factor Xa inhibitors are also being tested in ACS. They are both in Phase II. For example, apixaban:

http://clinicaltrials.gov/show/NCT00313300

Also, Dabigatran RE-DEEM trial is 6 month treatment. I assume that Momenta's drug is in hospital treatment since it is IV - so do you consider the two drugs competitors?